THC Suppressed Multiple Immune Cell Types in Labs and Animals, but Direct Evidence in Humans Was Missing | Research

The takeaway

A 1998 review found THC suppressed macrophages, T cells, and natural killer cells and decreased resistance to bacterial, viral, and parasitic infections in lab and animal studies, but definitive evidence linking marijuana use to increased infection in humans was unavailable.

Read this if you want to understand the evidence gap between laboratory findings on cannabis and immunity versus what happens in actual human users.

Definitive data linking marijuana use to increased human infection was unavailable

What the researchers found

This review synthesized the evidence on THC and immune function, finding consistent immunosuppressive effects across multiple experimental models.

THC decreased host resistance to bacterial, protozoan, and viral infections in lab and animal studies. The primary immune cells affected were macrophages (first-line defenders), T lymphocytes (adaptive immunity coordinators), and natural killer cells (which target infected and cancerous cells).

However, the review drew an important distinction: definitive data directly linking marijuana use to increased susceptibility to infection in living humans was currently unavailable. The evidence was extrapolated from in vitro and animal studies, which supported the hypothesis that similar effects would occur in humans but had not confirmed it.

Why it matters

This review highlighted a persistent gap in cannabis immunology: extensive laboratory evidence of immunosuppression but limited clinical confirmation in humans. This gap remains partially unfilled, making it one of the longest-standing unanswered questions in cannabis research.

The numbers in context

Three major immune cell types affected: macrophages, T lymphocytes, natural killer cells. Three categories of infection with reduced resistance: bacterial, protozoan, viral.

How the study worked

Narrative review of experimental studies examining THC effects on immune function across in vitro models, animal studies, and human data. Covered macrophage, T cell, and NK cell responses and host resistance to various infectious agents.

What this study cannot tell us

The review acknowledged that definitive human data was unavailable. Animal and in vitro models use different doses, routes, and exposure durations than human cannabis use. The THC concentrations used in lab studies often exceed physiological levels.

How to read the evidence

A narrative review synthesizing extensive lab and animal data. Limited by the acknowledged absence of definitive human evidence.

When this study was published

Published in 1998. The endocannabinoid system's role in immune regulation has been further characterized since, adding complexity to the simple immunosuppression model.

The bigger picture

The disconnect between strong lab evidence and weak clinical evidence for cannabis immunosuppression may reflect the immune system's redundancy and compensatory mechanisms. In living organisms, suppression of one pathway may be compensated by others, explaining why test-tube findings do not always translate to real-world infections.

Questions still open

Why has the lab-to-human translation been so difficult to demonstrate? Does the endocannabinoid system's role in immune regulation complicate simple immunosuppression narratives? Are immunocompromised populations at genuinely increased risk?

Common questions

Does cannabis weaken the immune system?

In lab and animal studies, THC consistently suppressed immune cell function. But as of 1998, definitive evidence that this translates to increased infections in human marijuana users was unavailable.

Which immune cells are affected?

Macrophages (first-line defenders), T lymphocytes (adaptive immunity), and natural killer cells (which target infected and cancerous cells) were the major targets of THC immunosuppression.

Read the original research

Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease.

Journal of neuroimmunology, 83(1-2), 116-23

View on PubMed ↗

Citation

Cabral, G A; Dove Pettit, D A. (1998). Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease.. Journal of neuroimmunology, 83(1-2), 116-23.